Produktart
Zustand
Einband
Weitere Eigenschaften
Gratisversand
Land des Verkäufers
Verkäuferbewertung
Verlag: Infobase Holdings, Inc., 2011
ISBN 10: 1617530476ISBN 13: 9781617530470
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Very Good. Updated. Used book that is in excellent condition. May show signs of wear or have minor defects.
Verlag: Facts On File, Incorporated, 2006
ISBN 10: 0791081435ISBN 13: 9780791081433
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Very Good. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects.
Verlag: Chelsea House Pub (L), 2002
ISBN 10: 0791067785ISBN 13: 9780791067789
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Good. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
Verlag: Facts On File, Incorporated, 2002
ISBN 10: 079107210XISBN 13: 9780791072103
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Good. Library Binding. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
Mehr Angebote von anderen Verkäufern bei ZVAB
Gebraucht ab EUR 5,95
Verlag: Infobase Holdings, Inc., 2005
ISBN 10: 0791087840ISBN 13: 9780791087848
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Good. Updated. Used book that is in clean, average condition without any missing pages.
Mehr Angebote von anderen Verkäufern bei ZVAB
Gebraucht ab EUR 12,26
Verlag: Facts On File, Incorporated, 2003
ISBN 10: 0791072312ISBN 13: 9780791072318
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Very Good. Library Binding. Used book that is in excellent condition. May show signs of wear or have minor defects.
Mehr Angebote von anderen Verkäufern bei ZVAB
Gebraucht ab EUR 12,29
Verlag: Facts On File, Incorporated, 2006
ISBN 10: 0791087972ISBN 13: 9780791087978
Anbieter: Better World Books, Mishawaka, IN, USA
Buch
Zustand: Very Good. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects.
Verlag: Chelsea House Publications, 2021
Anbieter: moluna, Greven, Deutschland
Buch
Zustand: New.
Verlag: Chelsea House Publications, 2021
Anbieter: moluna, Greven, Deutschland
Buch
Zustand: New.
Verlag: Nova Science Publishers, Inc, 2015
ISBN 10: 1634834933ISBN 13: 9781634834933
Anbieter: Buchpark, Trebbin, Deutschland
Buch
Zustand: Sehr gut. Zustand: Sehr gut - Gepflegter, sauberer Zustand. | Seiten: 184 | Sprache: Englisch.
Verlag: Springer International Publishing, 2023
ISBN 10: 3030874826ISBN 13: 9783030874827
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development.In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD),Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines.The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence.Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs.
Verlag: Springer International Publishing, 2022
ISBN 10: 3030874796ISBN 13: 9783030874797
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development.In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD),Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines.The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence.Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs.